Genetics Expert · $500M+ in Case Outcomes

Specialties & Experience of this Expert Witness

Additional Information

Dr. Sajel Lala Kana is a distinguished clinical geneticist with extensive expertise in genetics and pediatrics. She is residency-trained in Pediatrics and is fellowship-trained in genetics. She is board-certified in Genetics by the American Board of Medical Genetics and Genomics (ABMGG). With over 15 years of experience in academia and clinical practice, Dr. Kana has successfully led numerous research projects, contributed to high-impact publications, and presented her work at prestigious conferences. She is a Fellow of both the American College of Medical Genetics and the American Academy of Pediatrics. She also has a passion for biotechnology and has consulted with numerous start-ups and industry giants. She has contributed her expert witness services to multiple successful outcomes collectively worth $500 million+ USD in damages collected. Key Achievements: - Chief architect for a first-of-its-kind automated managed care product for genetics, acquired by Centene Corporation for over $650 million *on day of launch*. - Consultant on global high-risk insurance claims for a Fortune 500 reinsurance company, advising on genetics-related matters. - Subinvestigator for various research studies, including personalized ex-vivo drug screening. - Subject matter expert - Wrote genetics and reinsurance book chapter for Brackenridge's Medical Selection of Life Risks (5th Edition), the premier, comprehensive reference for life insurance underwriting, mortality analysis, and medical risk appraisal. Current Roles: Founder, NotBrands: Dr. Kana has developed a patent-pending supplement, Focused, using her deep subject matter expertise in metabolism. It is now commercially available for purchase (Instagram: @focusedsupp; Website: www.notbrands.com) Clinical Geneticist, Pediatric Specialists of America: Dr. Kana has been serving at Nicklaus Children’s Health System, Miami, FL, since 2018. She is an attending physician in clinical genetics, genomics, prenatal, mitochondrial & metabolism, among other areas. She is involved in personalized medicine initiatives and clinical research, including ex-vivo cancer drug screening. Genetics Consultant, PPD/Thermo Fisher Scientific: Since 2023, Dr. Kana has been consulting on early development, pharmacovigilance, and post-approval services. She is a member of the scientific advisory committee for teratology and a congenital malformation adjudicator. Consultant, Reinsurance Group of America: Dr. Kana advises on high-risk insurance claims and genetics-related company matters, including acquisitions and investments. Physician Clinical Reviewer, Centene Corporation/Evolent: Dr. Kana developed automated managed care and prior authorization product lines, leveraging her expertise in genetics-related billing and utilization management. Education: Fellowship in Clinical Genetics and Metabolism: Icahn School of Medicine, Mt. Sinai, New York, NY Residency in General Pediatrics: Louisiana State University, Shreveport, LA Doctor of Medicine: St. George’s University, Grenada, West Indies Bachelor of Science (Summa Cum Laude): Central Connecticut State University Research & Publications: Dr. Kana has authored numerous publications in esteemed journals and has been a peer reviewer for Nature Research, Orphanet Journal of Rare Diseases, and the European Journal of Human Genetics. Her research includes studies on mosaic conditions, congenital vascular lesions, and the value of rapid whole genome sequencing in complex congenital heart disease. Teaching & Mentorship: As an Assistant Professor at Florida International University, Dr. Kana has mentored and taught junior faculty, residents, and medical students. Her dedication to education extends to her role as an invited lecturer at various conferences and board review sessions. *If you want someone meticulous to help you find the hidden gems in your case, it has been proven time and time again that she is the person to do it.*